Center for the Economics of Reproductive HealthAdministrator2024-06-20T10:24:28-05:00

The Center for the Economics of Reproductive Health

The Center for the Economics of Reproductive Health at the Institute for Women’s Policy Research (IWPR) seeks to advance public understanding and awareness of the link between access to reproductive health care services for women and their long-term economic security and well-being. We conduct original research and policy analysis at the intersections of race, ethnicity, class, and reproductive health to improve economic outcomes, and educational and employment opportunities for all women.

CERH analysis release Oct 24
New IWPR Analysis Reveals Economic Harm of State Abortion Bans

IWPR's latest report points to a clear correlation between abortion restrictions and economic underperformance, further highlighting that restrictions or total bans on abortion care not only jeopardize women’s health but actively harm state economies.

SC EMTALA decision June 2024
Supreme Court Allows Access to Emergency Abortion Care in Idaho for Now

The Supreme Court has blocked Idaho from enforcing its extreme abortion ban in cases where a pregnant emergency room patient may need an abortion to protect their health. But this issue is far from resolved and the risk to women remains.

SC mife decision June 2024
Supreme Court Rejects Far Right Effort to Restrict Access to Medication Abortions and Mifepristone

"The far-right effort to block access to mifepristone is not about women’s safety—it is about controlling women’s choices and curtailing their freedoms. It is part of a broader crusade to impose their own ideology on women in this country and prevent them from making their own reproductive health care decisions. Today, we celebrate this decision, but we must remain vigilant against such attacks.”
--IWPR President Dr. Jamila K. Taylor

previous arrowprevious arrow
next arrownext arrow

The Continued Fight for Abortion Access in Florida

Last month, the Florida Supreme Court turned back the clock on reproductive justice in a big way when it upheld the state’s six-week abortion ban. Despite the detrimental 15-week ban that has been in effect since the 2022 Dobbs decision, Florida has remained a southern [...]

By Shannon Emmett|May 1, 2024|

Supreme Court Known for the Overturn of Roe v. Wade Tackles Medication Abortion, but the Safety and Effectiveness of Mifepristone Is Not in Question

FOR IMMEDIATE RELEASE March 26, 2024 Contact: William Lutz 202-785-5100 Supreme Court Known for the Overturn of Roe v. Wade Tackles Medication Abortion, but the Safety and Effectiveness of Mifepristone Is Not in Question Washington, D.C. --- The Institute for Women’s Policy Research’s President and [...]

By William Lutz|March 26, 2024|